Director/PDMR Shareholding

Summary by AI BETAClose X

Quantum Helium Limited announced that Non-Executive Director Graham Duncan purchased 17,000,100 Ordinary Shares at 0.032 pence per share on April 22, 2026. Following this transaction, Mr. Duncan holds a beneficial interest in 117,250,717 Ordinary Shares, representing 0.23% of the Company's total voting rights, which reflects the enlarged share capital after a recent £5 million institutional placing.

Disclaimer*

Quantum Helium Limited
23 April 2026
 

 

23 April 2026

 

Quantum Helium Limited

("Quantum" or the "Company")

 

 

Director / PDMR Shareholding

Quantum Helium Limited (AIM: QHE) announces that Non-Executive Director Graham Duncan has informed the Company that on 22 April 2026 he purchased 17,000,100 Ordinary Shares in the Company at a price of 0.032 pence per share.

Following these trades, Graham Duncan has a beneficial interest in 117,250,717 Ordinary Shares, representing 0.23% of the current total voting rights of the Company.

Note: The figure used to determine the Company's current total voting rights reflects the enlarged share capital following the announcement on 17 April 2026 of a £5 million institutional placing and the issue of 16,666,666,667 new ordinary shares, resulting in total voting rights of 49,985,396,722.

 

Enquiries:

Quantum Helium Limited

Carl Dumbrell

Chairman

 

NOMAD and Joint Broker

SP Angel Corporate Finance LLP

Stuart Gledhill / Richard Hail / Adam Cowl

+44 (0) 20 3470 0470

Brand Communications

Alan Green

Tel: +44 (0) 7976 431608

Joint Broker

CMC Markets UK Plc

Douglas Crippen

+44 (0) 020 3003 8632

Joint Broker

OAK Securities

Jerry Keen / Robert Bell

Tel: +44 (0) 203 973 3678

 

 

 

 

Updates on the Company's activities are regularly posted on its website: www.quantum-helium.com

 

Notes to editors

Quantum (AIM: QHE) is a helium, hydrogen and hydrocarbon exploration, development, and production company with projects in the US and Australia. Quantum's strategic objectives remain consistent: to identify opportunities which will provide operating cash flow and have development upside, in conjunction with progressing exploration. The Company has several projects in the US, in addition to royalty interests in Australia.

 

 

 

1.

Details of PDMR/person closely associated with them ("PCA")

a)

Name

Graham Duncan

2.

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/
amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Quantum Helium Limited

b)

Legal Entity Identifier code

213800PWZID9URNNGZ54

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of Quantum Helium Ltd



AU0000XINET1

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)


Price(s)

Volume(s)

 

 

 

 

 

 

 

 

0.032p

 

 

 

 

 

 

17,000,100

 



d)

Aggregated information

-     Aggregated volume

-     Price

 

Single transaction as in 4c) above

e)

Date of the transaction

22 April 2026

 

 

f)

Place of the transaction

London Stock Exchange

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings